Regina Galera
Director, Regulatory and Clinical Consulting, Life Sciences and Healthcare
Regina is a MSc Industrial Pharmacist by the University of Barcelona with over 19 years of experience in the Pharmaceutical and Medical Device Industry. She is a seasoned professional within the Regulatory, Clinical, Quality and Vigilance fields across EMEA, North America, Latin America, Asia Pacific and Japanese markets.
She has experience both in Industry with international companies such as Alcon (Novartis), Smith & Nephew and Olympus as well as in Consulting (IQVIA) interacting with Competent Authorities, Notified Bodies, Certification Bodies and Third-party auditors. Among others, she has worked with ophthalmic drugs, antibiotics, anesthetics, aesthetic products, combination products, class I-III medical devices, including implantable, custom-made, active and software as a medical device (SaMD).
She leads a team of experienced consultants who are focused on developing strategic technology enabled customized Regulatory and Clinical solutions with a holistic approach for Pharmaceuticals, Biologics, Medical Devices, Combination products and Consumer Health covering more than 140 countries.
Latest news
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release
The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…
Clarivate and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes
This collaboration combines the scientific and commercial expertise of Clarivate’s Life Sciences & Healthcare Consulting practice with KYBORA’s global transaction execution capabilities to accelerate life sciences transactions London, U.K., August…
Clarivate Enhances SkyRiver to Help Libraries Share, Reuse and Create Trusted Metadata
Combining community metadata sharing, institutional choice and AI-powered record creation LONDON, UK, August 12, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the…